Mercer Global Advisors
RMD icon

Mercer Global Advisors’s ResMed RMD Stock Holding History

Mercer Global Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6M Sell
65,155
-4,752
-7% -$1.18M 0.02% 403
2025
Q4 		$16.8M Sell
69,907
-6,650
-9% -$1.7M 0.03% 370
2025
Q3 		$21M Sell
76,557
-465
-0.6% -$127K 0.04% 301
2025
Q2 		$19.9M Buy
77,022
+10,345
+16% +$2.47M 0.04% 246
2025
Q1 		$14.9M Buy
66,677
+46,578
+232% +$10.9M 0.03% 278
2024
Q4 		$4.6M Buy
20,099
+1,249
+7% +$301K 0.01% 563
2024
Q3 		$4.5M Buy
18,850
+13,026
+224% +$2.91M 0.01% 522
2024
Q2 		$1.09M Sell
5,824
-270
-4% -$54.8K ﹤0.01% 931
2024
Q1 		$1.2M Buy
6,094
+2,450
+67% +$449K ﹤0.01% 893
2023
Q4 		$627K Sell
3,644
-309
-8% -$47.5K ﹤0.01% 1188
2023
Q3 		$584K Sell
3,953
-76
-2% -$13.7K ﹤0.01% 1176
2023
Q2 		$880K Buy
4,029
+62
+2% +$13.8K ﹤0.01% 988
2023
Q1 		$869K Sell
3,967
-810
-17% -$176K ﹤0.01% 964
2022
Q4 		$994K Buy
4,777
+61
+1% +$13.4K 0.01% 916
2022
Q3 		$1.03M Sell
4,716
-68
-1% -$15.5K 0.01% 831
2022
Q2 		$1M Buy
4,784
+790
+20% +$168K 0.01% 845
2022
Q1 		$969K Sell
3,994
-295
-7% -$71.4K 0.01% 912
2021
Q4 		$1.12M Buy
4,289
+21
+0.5% +$5.45K 0.01% 834
2021
Q3 		$1.13M Sell
4,268
-3
-0.1% -$820 0.01% 805
2021
Q2 		$1.05M Buy
4,271
+88
+2% +$18.5K 0.01% 811
2021
Q1 		$812K Buy
4,183
+317
+8% +$63.6K 0.01% 871
2020
Q4 		$822K Buy
3,866
+880
+29% +$175K 0.01% 672
2020
Q3 		$512K Buy
2,986
+221
+8% +$40.8K 0.01% 775
2020
Q2 		$531K Sell
2,765
-1
-0% -$164 0.01% 661
2020
Q1 		$407K Buy
2,766
+1,013
+58% +$161K 0.01% 722
2019
Q4 		$272K Sell
1,753
-27
-2% -$3.89K 0.01% 955
2019
Q3 		$240K Buy
1,780
+22
+1% +$2.88K 0.01% 975
2019
Q2 		$215K Sell
1,758
-187
-10% -$20.7K 0.01% 1023
2019
Q1 		$202K Buy
+1,945
New +$201K 0.01% 983

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mercer Global Advisors's RMD Position: Q1 2026 in Review

Mercer Global Advisors reduced its ResMed (RMD) stake by 6.8% in Q1 2026, selling an estimated $1.18M and leaving 65,155 shares worth $14.6M. The position accounts for 0.02% of the portfolio, ranked #403.

Mercer Global Advisors first reported a position in RMD in Q1 2019 and has held it in 29 quarters since. The position peaked at $21M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Mercer Global Advisors held 65,155 shares of ResMed worth $14.6M as of Q1 2026.
  • Mercer Global Advisors sold 4,752 ResMed shares in Q1 2026, an estimated $1.18M.
  • ResMed made up 0.02% of Mercer Global Advisors's portfolio in Q1 2026, its #403 holding.
  • Mercer Global Advisors first reported a position in ResMed in Q1 2019 and has held it in 29 quarters since.
  • Mercer Global Advisors's ResMed position peaked at $21M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.